A Vancouver-based company that analyzes blood samples to assess potential health risks has secured new capital to help scale its operations.
Molecular You announced Wednesday it has closed a $5-million Series A financing round, led by U.S.-based Voloridge Health, a data science-driven health technology firm.
Other investors in the round include Dynamic Leap, which focuses on investing in early-stage emerging technology companies.
“We plan to use this capital to grow our customer base across both consumer and clinical channels in North America and build our revenue,” said Jim Kean, CEO of Molecular You.
Founded in Vancouver in 2014, Molecular
→ Continue reading at BIV